Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Success Factors of ACHEMA 2012 Include Highest Ever International Participation

By LabMedica International staff writers
Posted on 09 Jul 2012
The 5-day ACHEMA 2012 exhibition congress for the chemical engineering, environmental protection, and biotechnology process industries (Frankfurt, Germany) concluded on June 22, after 167,000 participants learned about a broad range of products and services presented by 3,773 exhibitors on a 136,400 m² exhibition area with a very well received new layout of halls. More...


Popular exhibition groups included Pumps, Compressors, Valves and Fittings, Instrumentation, Control and Automation Techniques, Laboratory and Analytical Techniques, "Thermal, "Mechanical Processes, and Pharmaceutical, Packaging and Storage Techniques. In all fields, particular attention was devoted to the major themes of energy and bio-economics.

With a proportion of foreign exhibitors of almost 50%, coming from 56 countries, the ACHEMA was more international than ever before, reflecting that in these highly globalised industries ACHEMA is a leading event. “Globalisation does not just mean Europeans and Americans going to Asia – increasingly, Asian exhibitors and visitors are coming to Europe," noted Dr. Thomas Scheuring, CEO of DECHEMA Ausstellungs-GmbH. This was also evident in that more than 200 Chinese and 150 Indian companies presented their ranges. Still, numerous European and US companies once again also used the opportunity to present their innovations.

The congress included 900 talks and numerous events of various types. Aspects expected to occupy the process industry in the coming future included energy generation and storage, and biomass processing. Talks on materials science, bionics, and chemistry parks also met with a great response. "We made the right selection of focus topics," said Prof. Dr. Kurt Wagemann, Executive Director of DECHEMA e.V.

Exhibitors and visitors expressed high satisfaction. "It was a very successful show for us; considerably better than in 2009, even better than 2006 before the crisis happened,” said Friedbert Klefenz, Bosch Packaging Technology. Karsten Just of Bartec Holding noted, "More noticeable than the numbers is the fact that the quality of the visitors was very high." And according to the results of the visitor survey, more than 83% of the visitors judged the quality of the ACHEMA as "good“ or "very good“.

The 31st ACHEMA will take place starting June 15, 2015, in Frankfurt and the 9th AchemAsia on May 13-16, 2013, in Beijing (China).

Related Links:

ACHEMA



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.